Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
CA Stocks

VET.TO Vermilion Energy (TSX) C$14.73 Feb 2026: Mar 4 earnings catalyst

February 27, 2026
4 min read
Share with:

The VET.TO stock price sits at C$14.73 intraday on 27 Feb 2026, up 2.79% on volume of 1,230,554 shares. Investors are focused on Vermilion Energy Inc.’s upcoming Q4 2025 results due 04 Mar 2026 and the March 5 webcast. This earnings event could move the TSX-listed name in Canada amid a strong Energy sector rally.

Earnings calendar and what to watch

Vermilion Energy (VET.TO) will report Q4 2025 results on 04 Mar 2026 after markets close and host a conference call on 05 Mar 2026. Analysts expect EPS of C$0.30 and revenue around C$384.74 million. We will watch realized commodity prices, production volumes, and cash flow per share.

Sponsored

Price action and intraday technicals for VET.TO stock

Shares trade at C$14.73 with a day range of C$14.69–C$14.86 and year high C$14.93. The 50-day average is C$12.45 and 200-day average is C$11.14. Momentum indicators show RSI 63.75 and ADX 29.89, suggesting an up-trend that could accelerate or pause around earnings.

Valuation and key financial metrics

Vermilion lists EPS C$0.67 and a PE of 21.69 on the latest quote. Market capitalization is about C$2,229,396,020.00 and dividend per share is C$0.52 for a yield near 3.58%. Free cash flow per share is C$2.42 and book value per share is C$17.55, which supports the current price level.

Analyst view and price targets

Analyst coverage is mixed with an average target near C$14.50 and a range from C$13.00 to C$18.50. Notable bank targets include National Bank Financial C$18.50, TD Securities C$14.00, and BMO C$13.00. Consensus leans toward a Hold, so earnings must beat to lift targets materially.

Meyka Grade and forecast for VET.TO stock

Meyka AI rates VET.TO with a score of 65.57/100 (B, HOLD). This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly C$11.29, quarterly C$10.99, and yearly C$5.60. Compared with the current price of C$14.73, those figures imply model-based moves of -23.37%, -25.36%, and -61.98% respectively. Forecasts are model-based projections and not guarantees.

Risks, opportunities and sector context

Vermilion is exposed to commodity price swings and regional operational risk across Canada, Europe, and Australia. The Energy sector YTD has gained 13.49%, lifting many peers. Upside catalysts include stronger gas prices or margin improvement; risks include lower realized prices and operational setbacks.

Final Thoughts

VET.TO stock trades at C$14.73 ahead of a key earnings release on 04 Mar 2026 and a webcast on 05 Mar 2026. Near-term upside depends on results versus market expectations (consensus EPS C$0.30) and management guidance on cash flow and capital allocation. Analysts show a target range C$13.00–C$18.50 with an average near C$14.50 (implied -1.54% vs current price). Meyka AI’s forecast model projects monthly C$11.29 and yearly C$5.60, which imply downside from today’s level; these are model outputs, not guarantees. For traders, watch realized prices, production, and free cash flow per share. For longer-term investors, the company’s book value C$17.55 and dividend C$0.52 support value arguments, but sector volatility and execution risk remain. We provide this as data-driven market analysis via Meyka AI, an AI-powered market analysis platform

FAQs

When will Vermilion report earnings and why does it matter for VET.TO stock?

Vermilion reports Q4 2025 results on 04 Mar 2026 with a webcast on 05 Mar 2026. Earnings will update production, realized prices, and cash flow figures that often drive short-term moves in VET.TO stock.

What are the key numbers to watch in the report for VET.TO stock?

Watch EPS versus street estimates (consensus C$0.30), revenue near C$384.74 million, production volumes, and free cash flow. These metrics directly affect VET.TO stock valuation and dividend coverage.

How does Meyka AI view VET.TO stock ahead of earnings?

Meyka AI rates VET.TO 65.57/100 (B, HOLD) and models monthly C$11.29 and yearly C$5.60. The model implies downside, but this is a projection and not a guarantee.

What analyst price targets and ranges should investors note for VET.TO stock?

Analyst targets range C$13.00–C$18.50 with an average near C$14.50. The range shows mixed views; an earnings beat is required for targets above C$15.00 to gain traction.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
12% average open rate and growing
Trusted by 4,200+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)